4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
4.640
-0.030 (-0.64%)
At close: Feb 21, 2025, 4:00 PM
4.870
+0.230 (4.96%)
After-hours: Feb 21, 2025, 5:44 PM EST
FDMT's stock price has decreased by -83.06% in the past year and price targets may not have had time to catch up.
4D Molecular Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Buy
Price Target
$36.33
Upside
+682.97%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $39 → $30 | Strong Buy | Maintains | $39 → $30 | +546.55% | Feb 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +675.86% | Feb 10, 2025 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $8 → $6 | Sell | Maintains | $8 → $6 | +29.31% | Jan 13, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $31 → $27 | Buy | Maintains | $31 → $27 | +481.90% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +675.86% | Jan 13, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $79 → $46 | Strong Buy | Maintains | $79 → $46 | +891.38% | Dec 18, 2024 |
| Morgan Stanley | Morgan Stanley | Sell Initiates $8 | Sell | Initiates | $8 | +72.41% | Nov 21, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $39 | Strong Buy | Maintains | $39 | +740.52% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +675.86% | Nov 14, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $40 → $39 | Buy | Maintains | $40 → $39 | +740.52% | Nov 14, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 23, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $38 → $39 | Strong Buy | Maintains | $38 → $39 | +740.52% | Sep 19, 2024 |
| Leerink Partners | Leerink Partners | Buy Reiterates $40 → $36 | Buy | Reiterates | $40 → $36 | +675.86% | Sep 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +675.86% | Sep 19, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +675.86% | Aug 9, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.